Cologne, Germany

Susanne Steinig


 

 

Average Co-Inventor Count = 11.3

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • Köln, DE (2013)
  • Cologne, DE (2013 - 2018)

Company Filing History:


Years Active: 2013-2018

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: **Exploring the Innovations of Inventor Susanne Steinig**

Introduction

Susanne Steinig is a prominent inventor based in Cologne, Germany, known for her significant contributions to the field of biomedical innovations. With an impressive portfolio of five patents, she has made remarkable strides in developing therapeutic antibodies that target key pathways involved in coagulation and inflammation.

Latest Patents

Among her latest inventions are two noteworthy patents. The first patent focuses on "Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)." This innovation entails isolated monoclonal antibodies that effectively bind to human tissue factor pathway inhibitor (TFPI), along with the isolated nucleic acid molecules encoding these antibodies. Moreover, she has developed pharmaceutical compositions that utilize these anti-TFPI monoclonal antibodies to treat deficiencies or defects in coagulation. Additionally, her methods for producing these antibodies are poised to enhance therapeutic strategies in coagulation-related disorders.

Her second significant patent centers on "Antibodies to TNFα." This patent outlines antibodies, antigen binding portions, and derivatives capable of binding to tumor necrosis factor alpha (TNFα). It also includes nucleic acids that encode these innovative antibodies, as well as the vectors and host cells housing these nucleic acids.

Career Highlights

Susanne Steinig has had an impactful career, with experience in leading pharmaceutical companies such as Bayer Healthcare LLC and Bayer Pharma Aktiengesellschaft. Her work primarily focuses on the development of monoclonal antibodies and other therapeutic agents aimed at combating serious health conditions.

Collaborations

Throughout her career, Steinig has collaborated with prominent figures in the industry, including Christian Votsmeier and Peter Scholz. These partnerships have played a crucial role in advancing her research and the successful application of her innovative inventions.

Conclusion

In conclusion, Susanne Steinig's contributions to the field of biomedical innovation are indeed noteworthy. Her latest patents and collaborations reflect her dedication to research and development in therapeutic antibodies. As she continues to work on groundbreaking inventions, her legacy in the field is sure to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…